These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 8161010)

  • 1. Front-loaded infusion therapy of rT-PA during active menstruation. A case report.
    Lee DW; Garza JL
    Angiology; 1994 Apr; 45(4):311-4. PubMed ID: 8161010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is thrombolytic therapy safe during active menstruation?
    Sekyema YF; Baltazar RF
    J Emerg Med; 1995; 13(3):345-8. PubMed ID: 7673627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case history: successful thrombolytic therapy in a patient with acute myocardial infarction.
    Sait YR
    Heart Lung; 1988 Nov; 17(6 Pt 2):782-6. PubMed ID: 3142824
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of recent myocardial infarction during menstruation--presentation of a case].
    Puzio B; Poloński L; Kuśnierz B
    Kardiol Pol; 1993 Aug; 39(8):113-4. PubMed ID: 8231006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombolytic therapy during active menstruation: a case report.
    Chop WM; Evans PJ; Felty K
    J Fam Pract; 1991 Jul; 33(1):79-81. PubMed ID: 1905343
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical application of intravenous thrombolytic therapy in acute myocardial infarction].
    Kanmatsuse K; Kajiwara N
    Nihon Naika Gakkai Zasshi; 1992 Aug; 81(8):1213-7. PubMed ID: 1431461
    [No Abstract]   [Full Text] [Related]  

  • 7. Front-loaded accelerated infusions of tissue plasminogen activator: putting a better foot forward.
    Vaughan DE; Braunwald E
    J Am Coll Cardiol; 1992 Apr; 19(5):1076-8. PubMed ID: 1552098
    [No Abstract]   [Full Text] [Related]  

  • 8. [Endovenous thrombolysis in acute myocardial infarct. The experience in a community hospital. An analysis of 120 patients].
    Jorge Sdo C
    Arq Bras Cardiol; 1992 Jul; 59(1):23-30. PubMed ID: 1341143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNK-tPA: a new thrombolytic for treatment of acute myocardial infarction.
    Johnson TJ
    S D J Med; 2000 May; 53(5):185-6. PubMed ID: 10835948
    [No Abstract]   [Full Text] [Related]  

  • 10. [Coronary thrombolysis with urokinase and t-PA--comparison of intracoronary thrombolysis and intravenous coronary thrombolysis].
    Motomiya T
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):782-9. PubMed ID: 12436616
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative fibrinolytic activity of front-loaded alteplase and the single-bolus mutants tenecteplase and lanoteplase during treatment of acute myocardial infarction.
    Al-Shwafi KA; de Meester A; Pirenne B; Col JJ
    Am Heart J; 2003 Feb; 145(2):217-25. PubMed ID: 12595837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous recombinant tissue-type plasminogen activator in acute myocardial infarction.
    Gao R; Chen J; Kou W; Yao K; Xu Y; Lu Z; Yu Q; Tao P; Ma J; Zhu J
    Chin Med Sci J; 1991 Sep; 6(3):132-5. PubMed ID: 1793874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thrombolytic agents, urokinase, tissue-type plasminogen activator and pro-urokinase--their routes of administration and dosage: comparison between intracoronary thrombolysis and intravenous coronary thrombolysis].
    Motomiya T
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():441-5. PubMed ID: 12735012
    [No Abstract]   [Full Text] [Related]  

  • 14. Tissue plasminogen activator in pediatric myocardial infarction.
    Krendel S; Pollack P; Hanly J
    Ann Emerg Med; 2000 May; 35(5):502-5. PubMed ID: 10783412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The influence of lipoprotein (a) in thrombolysis with r-TPA for myocardial infarction].
    Santos Filho RD; Tranchesi Júnior B; Caramelli B; Barbosa V; Gebara O; de Albuquerque CP; Vinagre C; Maranhão R; Pileggi F
    Arq Bras Cardiol; 1991 Jul; 57(1):9-12. PubMed ID: 1823766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of acute myocardial infarction during pregnancy with tissue plasminogen activator.
    Schumacher B; Belfort MA; Card RJ
    Am J Obstet Gynecol; 1997 Mar; 176(3):716-9. PubMed ID: 9077638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intravenous recombinant tissue-type plasminogen activator in acute myocardial infarction].
    Gao R
    Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Aug; 19(4):228-30, 267-8. PubMed ID: 1813288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [t-PA in thrombolytic therapy of acute myocardial infarct].
    Rutsch W; Schmutzler H
    Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reinfarction after thrombolytic therapy. Results obtained with readministration of thrombolytic agent in 3 patients].
    Jorge Sdo C
    Arq Bras Cardiol; 1993 Mar; 60(3):177-82. PubMed ID: 8250747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thrombolytic therapy with tissue-type plasminogen activator].
    Toma M; Yamaguchi T
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):797-801. PubMed ID: 12436618
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.